Comparative Safety of Fibrate Drugs: a Pharmacovigilance Study of Fenofibrate and Gemfibrozil
Song, J.; Dou, C.-Y.; Chen, X.-M.; Hu, J.; Xu, F.; Li, L.-C.; Li, J.; Jiang, Q.; Zheng, W.
Show abstract
Withdrawal StatementThe authors have withdrawn this manuscript because We request withdrawal as the current version is incomplete and requires additional experimental data. Therefore, the authors do not wish this work to be cited as reference for the project. If you have any questions, please contact the corresponding author.
Matching journals
The top 1 journal accounts for 50% of the predicted probability mass.
Similar papers in this journal
- Large-scale empirical identification of candidate comparators for pharmacoepidemiological studies 94%
- Standardization of drug names in the FDA Adverse Event Reporting System: The DiAna dictionary 94%
- Patient-Reported Reasons for Antihypertensive Medication Change: A Quantitative Study Using Social Media 93%
Similar papers in this journal
- A Novel Computer-Assisted Drug-Induced Liver Injury Causality Assessment Tool (DILI-CAT) 94%
- Effect of common maintenance drugs on the risk and severity of COVID-19 in elderly patients 94%
- Clinical safety and pharmacokinetics of a novel oral niclosamide formulation compared with marketed niclosamide chewing tablets in healthy volunteers: a three-part randomized, double-blind, placebo-controlled trial 93%
Similar papers in this journal
- Data-driven methodology for discovery and response to pulmonary symptomology in hypertension through AI and machine learning: Application to COVID-19 related pharmacovigilance 94%
- Systematic analysis of electronic health records identifies drugs reducing risk of COVID-19 hospitalization and severity 94%
- Associations of proton pump inhibitors with susceptibility to influenza, pneumonia, and COVID-19: Evidence from a large population based cohort study 91%
Similar papers in this journal
- DrugWAS: Leveraging drug-wide association studies to facilitate drug repurposing for COVID-19 94%
- Innovative Randomized Phase 1 Study and Dosing Regimen Selection to Accelerate and Inform Pivotal COVID-19 Trial of Nirmatrelvir 93%
- SLCO1B1 functional variants and statin-induced myopathy in people with recent genealogical ancestors from Africa: a population-based real-world study 92%
Similar papers in this journal
- A comprehensive assessment of statin discontinuation among patients who concurrently initiate statins and CYP3A4-inhibitor drugs; a multistate transition model 94%
- Population Pharmacokinetic Analysis of Dexmedetomidine in Children using Real-World-Data Obtained from Electronic Health Records and Remnant Clinic Samples 93%
- People exposed to proton pump inhibitors shortly preceding COVID-19 diagnosis are not at an increased risk of subsequent hospitalizations and mortality: a nation-wide matched cohort study 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.